Mesenchymal Stem/Stromal Cells: MESENCURE: A PROFESSIONALIZED CELL THERAPY FOR ARDS REDUCED THE MORTALITY OF SEVERE COVID-19 PATIENTS BY 68% ACCORDING TO A RECENTLY CONCLUDED MULTI-CENTER, CONTROLLED PHASE II STUDY

Saved in:
Bibliographic Details
Published in:Cytotherapy (Oxford, England) England), 2022-05, Vol.24 (5), p.S31-S32
Main Authors: Bronshtein, T., David, D. Ben, Novak, A., Kivity, V., Hayek, T., Rozen, N., Meretzki, S., Hamoud, S.
Format: Article
Language:English
Subjects:
Oral Abstracts
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:1465-3249
1477-2566
DOI:10.1016/S1465-3249(22)00134-7